Cambridge Cognition

March 2022

We are delighted to announce that we have been appointed as Nominated Adviser and Joint Broker to Cambridge Cognition.

Cambridge Cognition is a technology company developing digital health products to better understand, detect and treat conditions affecting brain health. It provides gold standard clinically validated software for measuring cognition in clinical trials and is used by all major pharma companies and specialist contract research organisations.



Contact Panmure Gordon

Other recent transactions like this